Christian Brander1 and Bruce D. Walker2
1AIDS Research Center, Massachusetts General Hospital, 149 13th Street, Room 5234,
2Charlestown, MA 02129, USA, and Harvard Medical School Boston, MA USA
Updated October 1997
Over the last ten years, the efforts of many laboratories have led to the identification of numerous HLA class I restricted CTL epitopes in most of the HIV-1 proteins. With the help of many other scientists, who generously contributed their unpublished data, we have created this list which includes only epitopes for which the restricting HLA class I molecule has been defined and for which peptide titration with truncated peptides have been performed. Since the last update of this CTL epitope list in 1997, four new epitopes have been included while two epitopes have been removed due to conflicting data regarding HLA restriction and definition of the minimal epitope, respectively. We consistently try to verify data regarding newly described CTL epitopes before their inclusion in this database. In order to keep this list as flawless and updated as possible it would be very helpful for us to receive information about newly identified epitopes as they become available. Also conflicting data, when brought to our attention, will be addressed to keep the database as accurate as possible. For comments and/or contributions to the CTL epitope list (C.B. or B.W.) or the database (B.K.) please call, write, or mail us at:
Bette Korber Christian Brander Bruce D. Walker phone: 505 665 4453 phone: 617 724 5789 phone: 617 724 8332 FAX: 505 665 3493 FAX: 617 726 5411 FAX: 617 726 4691 btk@t10.lanl.gov Brander@Helix.MGH.Harvard.Edu BWalker@Helix.MGH.Harvard.Edu Table-1 Best Defined HIV CTL Epitopes HLA Protein AA Isolate Sequence Reference HLA-A2 2 C Falk91 L V I L p17 77-85 LAI SLYNTVATL Johnson91,Parker92,Parker94 RT 33-41 LAI ALVEICTEM Haas98 RT 346-354 LAI VIYQYMDDL Harrer96 RT 476-484 LAI ILKEPVHGV Walker89,Tsomides91 A*0201 gp120 311-320 III-B RGPGRAFVTI Alexander-Miller96 gp41 818-827 LAI SLLNATDIAV Dupuis95 nef 136-145 LAI PLTFGWCYKL Haas96, B. Maier and B. Autran, Per.comm. nef 180-189 LAI VLEWRFDSRL Haas96, B. Maier and B. Autran, Per.comm. HLA-A3.1 23 C DiBrino93 IF K L Y p17 18-26 LAI KIRLRPGGK Harrer96b p17 20-28 LAI RLRPGGKKK B. Culmann, D. Lewinsohn, D. Ruhl, S. Riddell, B. Wilkes, Per.comm. Goulder97 p17 20-29 LAI RLRPGGKKKY B. Wilkes, D. Ruhl, Per.comm. RT 33-43 LAI ALVEICTEMEK Haas98 RT 325-333 LAI AIFQSSMTK Threlkeld97 gp120 37-46 LAI TVYYGVPVWK Johnson94 gp41 775-785 LAI RLRDLLLIVTR Takahashi91 nef 73-82 LAI QVPLRPMTYK Koenig90,Culmann91 HLA-A11 2 C Zhang93 I K L p17 84-92 LAI TLYCVHQRI T. Harrer, Per.comm. p24 349-359 III-B ACQGVGGPGGHK Sipsas97 RT 325-333 LAI AIFQSSMTK Johnson94b,Zhang93,Threlkeld97 RT 508-517 LAI IYQEPFKNLK B. Culmann, Per.comm. nef 75-82 LAI PLRPMTYK Culmann91 nef 84-92 LAI AVDLSHFLK Culmann91 HLA-A19 A*7401 RT 71-79 Clade A/B/D ITLWQRPLV S. Rowland-Jones, Per.comm. HLA-A24 p17 28-36 LAI KYKLKHIVW D. Lewinsohn, Per.comm. p24 296-306 HIV-1 Clade A RDYVDRFFKTL S. Rowland-Jones, Per.comm. gp120 53-62 LAI LFCASDAKAY Lieberman92,Shankar96 gp41 591-598 LAI YLKDQQLL Dai92 Nef 138-147 LAI RYPLTFGW Goulder97e HLA-A25 p24 145-155 LAI QAISPRTLNAW I. Kurane, K. West, Per.comm. p24 203-212 LAI ETINEEAAEW Klenerman96,vanBaalen96 HLA-A26 p24 167-175 LAI EVIPMFSAL Goulder96b RT 593-603 LAI ETFYVDGAANR B. Wilkes, D. Ruhl, Per.comm. HLA-A28 A*6802 RT 71-79 Clade A/B/D ITLWQRPLV S. Rowland-Jones, Per.comm. A*6802 RT 85-93 Clade D DTVLEEMNL S. Rowland-Jones, Per.comm. HLA-A29 gp120 376-384 LAI FNCGGEFFY Wilson97 HLA-A31 gp41 775-785 LAI RLRDLLLIVTR Safrit94a,Safrit94b HLA-A32 RT 559-568 LAI PIQKETWETW Harrer96b gp120 419-427 HXB2 RIKQIINMW Harrer96b HLA-B7 123 C Englehard93 APR L p24 148-156 LAI SPRTLNAWV D. Lewinsohn, Per.comm. p24 179-187 LAI ATPQDLNTM B. Wilkes, D. Ruhl, Per.comm. RT 323-332 LAI SPAIFQSSMT C. Hey and D. Ruhl, Per.comm. gp120 303-312 LAI RPNNNTRKSI Safrit94b gp41 843-851 LAI IPRRIRQGL B. Wilkes and D. Ruhl, Per.comm. nef 68-77 LAI FPVTPQVPLR Haas96, B. Maier and B. Autran, Per.comm. nef 77-85 LAI RPMTYKAAL Bauer97 nef 128-137 LAI TPGPGVRYPL CulmannPenciolelli94,Haas96, B. Maier and B. Autran, Per.comm. HLA-B8 23 5 C Hill92b,Sutton93 P R L LK K I M p17 24-31 LAI GGKKKYKL RowlandJones93a,Goulder97 p17 74-82 LAI ELRSLYNTV Goulder97c p24 260-267 LAI EIYKRWII Sutton93,Goulder97c gp120 2-10 III-B RVKEKYQHL Sipsas97 gp41 591-598 LAI YLKDQQLL Johnson92,Shankar96 nef 13-20 LAI WPTVRERM Goulder97c nef 90-97 LAI FLKEKGGL CulmannPenciolelli94,Price97 HLA-B14 23 56 C DiBrino94b RL RI L KY HL F p24 298-306 LAI DRFYKTLRA Harrer96b gp41 589-597 LAI ERYLKDQQL Johnson92 HLA-B15 gp120 375-383 LAI SFNCGGEFF Wilson97 HLA-B18 p24 293-302 HIV-1 clade B/D FRDYVDRFYK Ogg98b nef 135-143 LAI YPLTFGWCY Culmann91,CulmannPenciolelli94 HLA-B27 2 C Jardetzky91 R K R p17 18-27 LAI KIRLRPGGKK D. Lewinsohn, Per.comm. p17 19-27 LAI IRLRPGGKK D. Lewinsohn, Per.comm. p24 263-272 LAI KRWIILGLNK Nixon88,Buseyne93 gp41 590-597 LAI RYLKDQQL Shankar96 gp41 791-799 LAI GRRGWEALKY Lieberman92, J. Lieberman, Per.comm. HLA-B*2703p24 265-274 HIV-2 RRWIQLGLQK RowlandJones98b B*2705 nef 105-114 LAI RRQDILDLWI Goulder97d nef 73-82 LAI QVPLRPMTYK B. Culmann, Per.comm. nef 134-141 LAI RYPLTFGW B. Culmann, Per.comm. HLA-B35 2 C Hill92b P Y S p17 124-132 JH31 NSSKVSQNY RowlandJones95 p17 36-44 LAI WASRELERF Goulder97a p24 254-262 U455 PPIPVGDIY RowlandJones95 RT 262-270 LAI TVLDVGDAY B. Wilkes, D. Ruhl, Per.comm. RT 273-282 III-B VPLDEDFRKY Sipsas97,Shiga96 RT 328-336 III-B NPDIVIYQY Sipsas97,Shiga96 RT 342-350 LAI HPDIVIYQY RowlandJones95 gp120 42-52 LAI VPVWKEATTTL B. Wilkes, D. Ruhl, Per.comm. gp41 611-619 LAI TAVPWNASW Johnson94 nef 74-81 LAI VPLRPMTY Culmann91,CulmannPenciolelli94 gag 245-253 HIV-2 NPVPVGNIY RowlandJones95 HLA-B37 nef 120-128 LAI YFPDWQNYT Culmann91 and Per.comm. HLA-B39 p24 193-201 LAI GHQAAMQML I. Kurane, K. West, Per.comm. HLA-B42 p17 20-29 LAI RLRPGGKKKY B. Wilkes, D. Ruhl, Per.comm. RT 438-446 LAI YPGIKVRQL B. Wilkes, D. Ruhl, Per.comm. HLA-B44 p24 306-316 SF2 AEQASQDVKNW Lewinsohn, Per.comm. gp120 30-38 SF33 AENLWVTVY Borrow97 HLA-B*4402&p24 294-304 HIV-1 Clade B RDYVDRFYKTL Ogg98b HLA-B45 RT 591-600 LAI GAETFYVDGA B. Wilkes, D. Ruhl, Per.comm. HLA-B51 p24 325-333 LAI NANPDCKTI B. Wilkes, D. Ruhl, Per.comm. RT 42-50 LAI EKEGKISKI Haas98 RT 295-302 III-B TAFTIPSI Sipsas97 gp41 557-565 III-B RAIEAQQHL Sipsas97 HLA-B52 p24 275-282 LAI RMYSPTSI B. Wilkes, D. Ruhl, Per.comm. HLA-B53 2 C Hill92b P Y F W HIV-2 gag 173-181 HIV-2 TPYDINQML Gotch93 HLA-B55 gp120 42-51 LAI VPVWKEATTT Shankar96 HLA-B57 p24 147-155 III-B ISPRTLNAW Johnson91,Goulder96 p24 140-149 LAI TSTLQEQIGW Goulder96 p24 162-172 LAI KAFSPEVIPMF Goulder96 p24 240-249 LAI TSTLQEQIGW Goulder96 p24 311-319 LAI QASQEVKNW Goulder96 p24 311-319 LAI QASQDVKNW Goulder96 nef 116-125 LAI HTQGYFPDWQ Culmann91 nef 120-128 LAI YFPDWQNYT Culmann91 HLA-B58 p24 240-249 LAI TSTLQEQIGW Goulder96 HLA-B60 p17 92-101 LAI IEIKDTKEAL A. Trocha and S. Kalams, Per.comm. HLA-Bw62 p17 20-29 LAI RLRPGGKKKY Johnson91, B. Wilkes, D. Ruhl, Per.comm. p24 268-277 LAI LGLNKIVRMY Johnson91 RT 415-426 III-B LVGKLNWASQIY P. Johnson, Per.comm. RT 476-485 LAI ILKEPVHGVY Johnson91, P. Johnson, Per.comm. nef 84-91 LAI AVDLSHFL CulmannPenciolelli94 nef 117-127 LAI TQGYFPDWQNY B. Culmann, Per.comm. HLA-Cw*01,02 p24 168-175 LAI VIPMFSAL P. Goulder in press HLA-Cw4 2 C Falk94 Y F P L F M gp120 380-388 LAI SFNCGGEFF Johnson93,Wilson97 C*0401 p24 308-316 LAI QASQEVKNW Buseyne97
REFERENCES:
1. [Alexander-Miller (1996)] M.A.Alexander-Miller, K.C.Parker, T.Tsukui, C.D.Pendleton, J.E.Coligan, & J.A.Berzofsky. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-1 Envelope protein to human cytotoxic T lymphocytes. Int Immunol 8:641-649, 1996.
2. [Bauer (1997)] M.Bauer, M.Lucchiari-Hartz, R.Maier, G.Haas, B.Autran, K.Eichmann, R.Frank, B.Maier, & A.Meyerhans. Structural constraints of HIV-1 Nef may curtail escape from HLA-B7-restricted CTL recognition. Immunol Lett 55:119-22, 1997.
3. [Borrow (1997)] P.Borrow, H.Lewicki, X.Wei, M.S.Horwitz, N.Peffer, H.Meyers, J.A.Nelson, J.E.Gairin, B.H.Hahn, M.B.Oldstone, & G.M.Shaw. Anti-viral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3:205-11, 1997.
4. [Buseyne (1993)] F.Buseyne, M.McChesney, F.Porrot, S.Kovarik, B.Guy, & Y.Riviere. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1 infected individuals: gag epitopes are clustered in three regions of the p24 gag protein. J Virol 67:694-702, 1993.
5. [Buseyne (1997)] F.Buseyne, S.Stevanovic, H.Rammensee, & Y.Riviere. Characterization of an HIV-1 p24 gag epitope recognized by a CD8+ cytotoxic T-cell clone. Immunol Lett 55(3):145-149, 1997.
6. [Culmann (1991)] B.Culmann, E.Gomard, M.Kieny, B.Guy, F.Dreyfus, A.Saimot, D.Sereni, D.Sicard, & J.Levy. Six epitopes with human cytotoxic CD8+ cells in the central region of the HIV-1 Nef protein. J Immunol 146:1560-1565, 1991.
7. [Culmann-Penciolelli (1994)] B.Culmann-Penciolelli, S.Lamhamedi-Cherradi, I.Couillin, N.Guegan, J.P. Levy, J.G. Guillet, & E.Gomard. Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein (published erratum appears in J Virol 1995 Jan;69(1):618). J Virol 68:7336-43, 1994.
8. [Dai (1992)] L.C. Dai, K.West, R.Littaua, K.Takahashi, & F.A. Ennis. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes. J Virol 66:3151-3154, 1992.
9. [DiBrino (1993)] M.DiBrino, K.C. Parker, & J.S. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc Natl Acad Sci USA 90:1508-1512, 1993.
10. [DiBrino (1994)] M.DiBrino, K.C. Parker, D.H. Margulies, J.Shiloach, R.V. Turner, M.Garfield, W.E.B. WE, & J.E. Coligan. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. J Biol Chem
11. [Dupuis (1995)] M.Dupuis, S.K. Kundu, & T.C. Merigan. Characterization of HLA-A*0201-restricted cytotoxic T-cell epitopes in conserved regions of the HIV type 1 gp160 protein. J Immunol 155:2232-2239, 1995.
12. [Englehard (1993)] V.H. Englehard, E.L. Huczko, & W.B. Peptides bound to HLA-B7 determined by mass spectrometry. J Cell Biochem Suppl 1993 17C:56, 1993.
13. [Falk (1994)] K.Falk, O.Rotzschke, & B.Grahavac. Allele-specific peptide motifs of HLA-C molecules. Proc Natl Acad Sci USA 90:12005-12009, 1994.
14. [Falk (1991)] K.Falk, O.Rotzschke, S.Stevanovic, G.Jung, & H.Rammensee. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-296, 1991.
15. [Gotch (1993)] F.Gotch, S.N. McAdam, & C.E.A. Cytotoxic T-cells in HIV-2 seropositive gambians. identification of a virus specific MHC-restricted peptide epitope. J Immunol 151:3361-3369, 1993.
16. [Goulder (1996a)]
P.Goulder, C.Conlon, K.McIntyre, & A.McMichael.
Identification of a novel human leukogen antigen A26-restricted
epitope in a conserved region of Gag.
AIDS 10(12):1441-1443, 1996a.
17. [Goulder (1997)]
P.Goulder, A.Sewell, D.Lalloo, D.Price, J.Whelan, J.Evans, G.Taylor,
G.Luzzi, P.Giangrande, R.Phillips, & A.J. McMichael.
Patterns of immunodominance in hiv-1-specific cytotoxic T
lymphocyte responses in two human histocompatibility leukocyte antigens
(HLA)-identical siblings with hla-a*0201 are influenced by epitope
mutation.
J Exp Med 8:1423-33, 1997.
18. [Goulder (1997)]
P.J. Goulder, A.Edwards, R.E. Phillips, & A.J. McMichael.
Identification of a novel HLA-A24-restricted cytotoxic
T-lymphocyte.
AIDS 11:1883-4, 1997.
19. [Goulder (1997a)]
P.J. Goulder, A.Edwards, R.E. Phillips, & A.J. McMichael.
Identification of a novel HLA-B*2705-restricted cytotoxic T
lymphocyte epitope within a conserved region of HIV-1 Nef.
AIDS 11:536-538, 1997a.
20. [Goulder (1997b)]
P.J. Goulder, A.Edwards, R.E. Phillips, & A.J. McMichael.
Identification of a novel HLA-B*3501-restricted cytotoxic T
lymphocyte epitope using overlapping peptides.
AIDS 11(7):930-932, 1997b.
21. [Goulder (1996b)]
P.J.R. Goulder, M.Bunce, P.Krausa, K.McIntyre, S.Crowley, B.Morgan,
A.Edwards, P.Giangrande, R.E. Phillips, & A.J. McMichael.
Novel, cross-restricted, conserved and immunodominant cytotoxic T
lymphocyte epitopes in slow HIV type 1 infection.
AIDS Res and Hum Retroviruses 12:1691-1698, 1996b.
22. [Goulder (1997c)]
P.J.R. Goulder, S.W. Reid, D.A. Price, C.A. O'Callaghan, A.J.
McMichael, R.E. Phillips, & E.Y. Jones.
Combined structural and immunological refinement of HIV-1 HLA-B8
restricted cytotoxic T lymphocyte epitopes.
Eur J Immunol 27:1515-1521, 1997c.
23. [Haas (1996)]
G.Haas, U.Plikat, P.Debre, M.Lucchiari, C.Katlama, Y.Dudoit,
O.Bonduelle, M.Bauer, H.Ihlenfeldt, G.Jung, B.Maier, A.Meyerhans, &
B.Autran.
Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T
lymphocytes in vivo.
J Immunol 157:4212-4221, 1996.
24. [Haas (1998)]
G.Haas, A.Samri, E.Gomard, A.Hosmalin, J.Duntze, J.M. Bouley,
H.G. Ihlenfeldt, C.Katlama, & B.Autran.
Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase
and protease.
AIDS 12:1427-36, 1998.
25. [Harrer (1996a)]
E.Harrer, T.Harrer, P.Barbosa, M.Feinberg, R.P. Johnson, S.Buchbinder, &
B.D. Walker.
Recognition of the highly conserved YMDD region in the human
immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted
cytotoxic T lymphocytes from an asymptomatic long-term nonprogresser.
J Inf Dis 173:476-479, 1996a.
26. [Harrer (1996b)]
T.Harrer, E.Harrer, S.A. Kalams, P.Barbosa, A.Trocha, R.P. Johnson,
T.Elbeik, M.B. Feinberg, S.P. Buchbinder, & B.D. Walker.
Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing
HIV-1 infection. breadth and specificity of the response and relation to in
vivo viral quasispecies in a person with prolonged infection and low viral
load.
J Immunol 156:2616-2623, 1996b.
27. [Hill (1992)]
A.V. Hill, J.Elvin, A.C. Willis, M.Aidoo, C.E. Allsopp, F.M. Gotch, X.M.
Gao, M.Takiguchi, B.M. Greenwood, & A.R.T.
Molecular analysis of the association of HLA-B53 and resistance to
severe malaria (see comments).
Nature 360:434-9, 1992.
28. [Jardetzky (1991)]
T.S. Jardetzky, W.S. Lane, R.A. Robinson, D.R. Madden, & D.C. Wiley.
Identification of self peptides bound to purified HLA-B27.
Nature 353:326-9, 1991.
29. [Johnson (1994)]
R.P. Johnson, S.A. Hammond, A.Trocha, R.F. Siliciano, & B.D. Walker.
Induction of a major histocompatibility complex class I-restricted
cytotoxic T-lymphocyte response to a highly conserved region of human
immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans
immunized with a candidate HIV-1 vaccine.
J Virol 68:3145-3153, 1994.
30. [Johnson (1992)]
R.P. Johnson, A.Trocha, T.M. Buchanan, & B.D. Walker.
Identification of overlapping HLA class I-restricted cytotoxic
T-cell epitopes in a conserved region of the human immunodeficiency virus
type 1 envelope glycoprotein: definition of minimum epitopes and analysis of
the effects of sequence variation.
J Exp Med 175:961-971, 1992.
31. [Johnson (1993)]
R.P. Johnson, A.Trocha, T.M. Buchanan, & B.D. Walker.
Recognition of a highly conserved region of human immunodeficiency
virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.
J Virol 67:438-445, 1993.
32. [Johnson (1991)]
R.P. Johnson, A.Trocha, L.Yang, G.P. Mazzara, D.L. Panicali, T.M.
Buchanan, & B.D. Walker.
HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple
highly conserved epitopes. fine specificity of the gag-specific response
defined by using unstimulated peripheral blood mononuclear cells and cloned
effector cells.
J Immunol 147:1512-1521, 1991.
33. [Johnson & Walker(1994)]
R.P. Johnson & B.D. Walker.
CTL in HIV-1 infection: Responses to structural proteins.
Curr Topics Microbiol Immunol 189:35-63, 1994.
34. [Klenerman (1996)]
P.Klenerman, G.Luzzi, K.McIntyre, R.Phillips, & A.McMichael.
Identification of a novel HLA-A25 restricted epitope in a conserved
region of p24 gag (positions 71-80).
AIDS 10:348-350, 1996.
35. [Koenig (1990)]
S.Koenig, T.R. Fuerst, L.V. Wood, R.M. Woods, J.A. Suzich, G.M. Jones,
V.F. de la Cruz, R.T. Davey Jr., S.Venkatesan, B.Moss, W.E.
Biddison, & A.S. Fauci.
Mapping the fine specificity of a cytotoxic T-cell response to
HIV-1 Nef protein.
J Immunol 145:127-135, 1990.
36. [Lieberman (1992)]
J.Lieberman, J.A. Fabry, M.Kuo, P.Earl, B.Moss, & P.R. Skolnik.
Cytotoxic T lymphocytes from HIV-1 seropositive individuals
recognize immunodominant epitopes in gp160 and reverse transcriptase.
J Immunol 148:2738-2747, 1992.
37. [Nixon (1988)]
D.Nixon, A.Townsend, J.Elvin, C.Rizza, J.Gallway, & A.McMichael.
HIV-1 gag-specific cytotoxic T lymphocytes defined with
recombinant vaccinia virus and synthetic peptides.
Nature 336:484-487, 1988.
38. [Ogg (1998)]
G.S. Ogg, T.Dong, P.Hansasuta, L.Dorrell, J.Clarke, R.Coker,
G.Luzzi, C.Conlon, A.P. McMichael, & S.Rowland-Jones.
Four novel cytotoxic T-lymphocyte epitopes in the highly conserved
major homology region of HIV-1 Gag, restricted through B*4402, B*1801,
A*2601, B*70 (B*1509).
AIDS 12:1561-3, 1998.
39. [Parker (1994)]
K.C. Parker, M.A. Bednarek, & J.E. Coligan.
Scheme for ranking potential HLA-A2 binding peptides based on
independent binding of individual peptide side-chains.
J Immunol 152, 1994.
40. [Parker (1992)]
K.C. Parker, M.A. Bednarek, L.K. Hull, U.Utz, B.C. H.J. Zweerink, W.E.
Biddison, & J.E. Coligan.
Sequence motifs important for peptide binding to the human MHC class
I molecule, HLA-A2.
J Immunol 149, 1992.
41. [Price (1997)]
D.A. Price, P.J. Goulder, P.Klenerman, A.K. Sewell, P.J. Easterbrook,
M.Troop, C.R. Bangham, & R.E. Phillips.
Positive selection of HIV-1 cytotoxic T lymphocyte escape
variants during primary infection.
Proc Natl Acad Sci USA 94:1890-5, 1997.
42. [Rowland-Jones (1998)]
S.Rowland-Jones, R.A. Colbert, T.Dong, S.McAdam, M.Brown,
K.Ariyoshi, S.Sabally, H.Whittle, & A.McMichael.
Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-
cell epitopes presented by HLA-B*2703 and B*2705.
AIDS 12:1391-3, 1998.
43. [Rowland-Jones (1993)]
S.L. Rowland-Jones, S.H. Powis, J.Sutton, I.Mockridge, F.M. Gotch,
N.Murray, A.B. Hill, W.M. Rosenberg, J.Trowsdale, & A.J. McMichael.
An antigen processing polymorphism revealed by HLA-B8-restricted
cytotoxic T lymphocytes which does not correlate with TAP gene
polymorphism.
Eur J Immunol 23:1999-2004, 1993.
44. [Rowland-Jones (1995)]
S.L. Rowland-Jones, J.Sutton, K.Ariyoshi, T.Dong, , F.Gotch,
S.McAdam, D.Whitby, S.Sabally, A.Gallimore, T.Corrah, M.Takiguchi,
T.Schultz, A.McMichael, & H.Whittle.
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected
Gambian women.
Nature Medicine 1:59-64, 1995.
45. [Safrit (1994a)]
J.T. Safrit, C.A. Andrews, T.Zhu, D.D. Ho, & R.A. Koup.
Characterization of human immunodeficiency virus type 1-specific
cytotoxic T lymphocyte clones isolated during acute seroconversion:
recognition of autologous virus sequences within a conserved immunodominant
epitope.
J Exp Med 179:463-472, 1994a.
46. [Safrit (1994b)]
J.T. Safrit, A.Y. Lee, C.A. Andrews, & R.A. Koup.
A region of the third variable loop of HIV-1 gp120 is recognized by
HLA-B7-Restricted CTLs from two acute seroconversion patients.
J Immunol 153:3822-3830, 1994b.
47. [Shankar (1996)]
P.Shankar, J.A. Fabry, D.M. Fong, & J.Lieberman.
Three regions of HIV-1 gp160 contain clusters of immunodominant
CTL epitopes.
Immunol Lett 52:23-30, 1996.
48. [Shiga (1996)]
H.Shiga, T.Shioda, H.Tomiyama, Y.Takamiya, S.Oka, S.Kimura, Y.Yamaguchi,
T.Gojoubori, H.G. Rammensee, K.Miwa, & M.Takiguchi.
Identification of multiple HIV-1 cytotoxic T-cell epitopes presented
by human leukocyte antigen B35 molecule.
AIDS 10:1075-1083, 1996.
49. [Sipsas (1997)]
N.V. Sipsas, S.A. Kalams, A.Trocha, S.He, W.A. Blattner, B.D. Walker, &
R.P. Johnson.
Identification of type-specific cytotoxic T lymphocyte responses to
homologous viral proteins in laboratory workers accidentally infected with
HIV-1.
J Clin Invest 99:752-62, 1997.
50. [Sutton (1993)]
J.Sutton, S.Rowland-Jones, W.Rosenberg, D.Nixon, F.Gotch, X.Gao,
N.Murray, A.Spoonas, P.Driscoll, M.Smith, A.Willis, & A.McMichael.
A sequence pattern for peptides presented to cytotoxic T
lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
Eur J Immunol 23:447-453, 1993.
51. [Takahashi (1991)]
K.Takahashi, L.Dai, T.R. Fuerst, W.E. Biddison, P.L. Earl, B.Moss, &
F.A. Ennis.
Specific lysis of human immunodeficiency virus type 1-infected cells
by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that
recognizes a conserved peptide sequence within the gp41 subunit of the
envelope protein.
Proc Natl Acad Sci USA 88:10277-10281, 1991.
52. [Threlkeld (1997)]
S.C. Threlkeld, P.A. Wentworth, S.A. Kalams, B.M. Wilkes, D.J. Ruhl,
E.Kepgh, J.Sidney, S.Southwood, B.D. Walker, & A.Sette.
Degenerate and promiscuous recognition by CTL of peptides presented
by the MHC class I A3-like superfamily.
J Immunol 159 (4):1648-1657, 1997.
53. [Tsomides (1991)]
T.J. Tsomides, B.D. Walker, & H.N. Eisen.
An optimal viral peptide recognized by CD8+ T-cells binds very
tightly to the restricting class I major histocompatibility complex protein
on intact cells but not to the purified class I protein.
Proc Natl Acad Sci USA 88:11276-11280, 1991.
54. [van Baalen (1996)]
C.A. van Baalen, M.R. Klein, R.C. Huisman, M.E. Dings, S.R. Kerkhof
Garde, A.M. Geretti, R.Gruters, C.A. van Els, F.Miedema, & A.D.
Osterhaus.
Fine-specificity of cytotoxic T lymphocytes which recognize
conserved epitopes of the gag protein of human immunodeficiency virus type 1.
J Gen Virol 77:1659-1665, 1996.
55. [Walker (1989)]
B.D. Walker, C.Flexner, K.Birch-Limberger, L.Fisher, T.J. Paradis,
A.Aldovini, R.Young, B.Moss, & R.T. Schooley.
Long-term culture and fine specificity of human cytotoxic
T-lymphocyte clones reactive with human immunodeficiency virus type 1.
Proc Natl Acad Sci USA 86:9514-9518, 1989.
56. [Wilson (1997)]
C.C. Wilson, S.A. Kalams, B.M. Wilkes, D.J. Ruhl, F.Gao, B.H. Hahn, I.C.
Hanson, K.Luzuriaga, S.Wolinsky, R.Koup, S.P. Buchbinder, R.P. Johnson,
& B.D. Walker.
Overlapping epitopes in human immunodeficiency virus type 1 gp120
presented by HLA A, B, and C molecules: effects of viral variation on
cytotoxic T-lymphocyte recognition.
J Virol 71:1256-64, 1997.
57. [Zhang (1993)]
Q.Zhang, R.Gavioli, G.Klein, & M.G. Masucci.
An HLA-All-specific motif in nonamer peptides derived from viral
and cellular proteins.
Proc Natl Acad Sci USA 90:2217-2221, 1993.